(L00-L99)
L62
BookmarkNail disorders in diseases classified elsewhere
Filed alongside this entry 305
under Disorder (of)
- acantholytic L11.9
- adjustment (grief) F43.20
- adrenal (capsule) (gland) (medullary) E27.9
- adrenogenital E25.9
- adult personality (and behavior) F69
- aggressive, unsocialized F91.1
- alcohol-related F10.99
- alveolar NEC J84.09
- anaerobic glycolysis with anemia D55.29
- anxiety F41.9
- aromatic amino-acid metabolism E70.9
- arteriole NEC I77.89
- artery NEC I77.89
- attention-deficit hyperactivity (adolescent) (adult) (child) F90.9
- attention-deficit without hyperactivity (adolescent) (adult) (child) F98.8
- auditory processing (central) H93.25
- autistic F84.0
- autism spectrum F84.0
- autoimmune D89.89
- autonomic nervous system G90.9
- bereavement, persistent complex F43.81
- beta-amino-acid metabolism E72.89
- bile acid and cholesterol metabolism E78.70
- bilirubin excretion E80.6
- binge eating F50.81
- bipolar (I) (seasonal) (type 1) F31.9
- bladder N32.9
- bleeding D68.9
- blood D75.9
- body dysmorphic F45.22
- bone M89.9
- brachial plexus G54.0
- branched-chain amino-acid metabolism E71.2
- breast N64.9
- Briquet's F45.0
- bullous, in diseases classified elsewhere L14
- cardiac, functional I51.89
- carnitine metabolism E71.40
- cartilage M94.9
- catatonia (due to known physiological condition) (with another mental disorder) F06.1
- catatonic NOS F06.1
- central auditory processing H93.25
- character NOS F60.9
- childhood disintegrative NEC F84.3
- cholesterol and bile acid metabolism E78.70
- choroid H31.9
- citrate metabolism NEC E74.829
- citrate transporter, SLC13A5 E74.820
- coagulation (factor) D68.9
- coccyx NEC M53.3
- cognitive F09
- communication F80.9
- conduct (childhood) F91.9
- conduction, heart I45.9
- congenital glycosylation (CDG) E74.89
- conjunctiva H11.9
- connective tissue, localized L94.9
- cornea H18.9
- corpus cavernosum N48.9
- Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5) G40.42
- cyclothymic F34.0
- defiant oppositional F91.3
- delusional (persistent) (systematized) F22
- depersonalization F48.1
- depressive F32.A
- developmental F89
- diaphragm J98.6
- digestive (system) K92.9
- disc (intervertebral) M51.9
- disinhibited attachment (childhood) F94.2
- disintegrative, childhood NEC F84.3
- disruptive F91.9
- dissocial personality F60.2
- dissociative F44.9
- dream anxiety F51.5
- drug induced hemorrhagic D68.32
- drug related F19.99
- dysmorphic body F45.22
- dysthymic F34.1
- ear H93.9
- eating (adult) (psychogenic) F50.9
- electrolyte (balance) NEC E87.8
- elimination, transepidermal L87.9
- emotional (persistent) F34.9
- endocrine E34.9
- erectile (male) (organic) N52.9
- esophagus K22.9
- eustachian tube H69.9
- exhibitionistic F65.2
- extrapyramidal G25.9
- eye H57.9
- eyelid H02.9
- feeding (infant or child) R63.30
- feigned (with obvious motivation) Z76.5
- fetishistic F65.0
- fibroblastic M72.9
- fluid balance E87.8
- follicular (skin) L73.9
- FOXG1-related QA0.0151
- frotteuristic F65.81
- fructose metabolism E74.10
- functional polymorphonuclear neutrophils D71.9
- gallbladder, biliary tract and pancreas in diseases classified elsewhere K87
- gambling F63.0
- gamma aminobutyric acid (GABA) metabolism E72.81
- gamma-glutamyl cycle E72.89
- gastric (functional) K31.9
- gastrointestinal (functional) NOS K92.9
- gender incongruence F64.9
- gender-identity or -role F64.9
- genito-pelvic pain penetration F52.6
- globe H44.9
- glomerular (in) N05.9
- gluconeogenesis E74.4
- glucose transport E74.819
- glycine metabolism E72.50
- glycoprotein metabolism E77.9
- habit (and impulse) F63.9
- heart action I49.9
- hematological D75.9
- hematopoietic organs D75.9
- hemorrhagic NEC D69.9
- histidine metabolism E70.40
- hoarding F42.3
- hyperleucine-isoleucinemia E71.19
- hypervalinemia E71.19
- hypoactive sexual desire F52.0
- hypochondriacal F45.20
- immune mechanism (immunity) D89.9
- impaired renal tubular function N25.9
- impulse (control) F63.9
- integument, newborn P83.9
- intermittent explosive F63.81
- involuntary emotional expression (IEED) F48.2
- iris H21.9
- iron metabolism E83.10
- isovaleric acidemia E71.110
- jaw, developmental M27.0
- joint M25.9
- ketone metabolism E71.32
- kidney N28.9
- lacrimal system H04.9
- lactation NEC O92.79
- language (developmental) F80.9
- late luteal phase dysphoric N94.89
- learning (specific) F81.9
- lens H27.9
- ligament M24.20
- liver K76.9
- lung, interstitial, drug-induced J70.4
- lymphoproliferative, post-transplant (PTLD) D47.Z1
- lysine and hydroxylysine metabolism E72.3
- major neurocognitive F03
- manic F30.9
- meninges, specified type NEC G96.198
- menopausal N95.9
- menstrual N92.6
- mental (or behavioral) (nonpsychotic) F99
- metabolic, amino acid, transitory, newborn P74.8
- metabolism NOS E88.9
- methylmalonic acidemia E71.120
- micturition NEC R39.198
- mild neurocognitive G31.84
- mitochondrial metabolism E88.40
- mood F39
- movement G25.9
- multiple personality F44.81
- muscle M62.9
- myoneural G70.9
- myotonic NEC G71.19
- nail, in diseases classified elsewhere L62
- neonatal onset multisystemic inflammatory (NOMID) M04.2
- nerve G58.9
- nervous system G98.8
- neurocognitive R41.9
- neurodevelopmental F89
- neurohypophysis NEC E23.3
- neurological NEC R29.818
- neuromuscular G70.9
- neurotic F48.9
- neutrophil, polymorphonuclear D71.9
- nightmare F51.5
- nose J34.9
- obsessive-compulsive F42.9
- odontogenesis NOS K00.9
- oppositional defiant F91.3
- orbit H05.9
- orgasmic (female) F52.31
- ornithine metabolism E72.4
- overanxious F41.1
- pancreatic internal secretion E16.9
- panic F41.0
- papulosquamous L44.9
- paranoid F22
- paraphilic F65.9
- parathyroid (gland) E21.5
- parietoalveolar NEC J84.09
- paroxysmal, mixed R56.9
- patella M22.9
- patellofemoral M22.2X
- pedophilic F65.4
- pentose phosphate pathway with anemia D55.1
- perception, due to hallucinogens F16.983
- peripheral nervous system NEC G64
- peroxisomal E71.50
- personality F60.9
- pervasive, developmental F84.9
- phobic anxiety, childhood F40.8
- phosphate-losing tubular N25.0
- pigmentation L81.9
- pinna (noninfective) H61.10
- pituitary gland E23.7
- platelet-activating anti-PF4, specified NEC D75.84
- platelets D69.19
- plexus G54.9
- polymorphonuclear neutrophils D71.9
- postconcussional F07.81
- posthallucinogen perception F16.983
- postmenopausal N95.9
- post-transplant lymphoproliferative D47.Z1
- post-traumatic stress (PTSD) F43.10
- premenstrual dysphoric (PMDD) F32.81
- prepuce N47.8
- propionic acidemia E71.121
- prostate N42.9
- psychogenic NOS F45.9
- psychological F99
- psychomotor NEC F44.4
- psychosexual F65.9
- puberty E30.9
- purine metabolism E79.9
- pyrimidine metabolism E79.9
- pyruvate metabolism E74.4
- reactive attachment (childhood) F94.1
- reading R48.0
- receptive language F80.2
- receptor, hormonal, peripheral E34.50
- recurrent brief depressive F33.8
- reflex R29.2
- refraction H52.7
- relationship F68.8
- REM sleep behavior G47.52
- renal function, impaired (tubular) N25.9
- resonance R49.9
- retina H35.9
- retroperitoneal K68.9
- right hemisphere organic affective F07.89
- rumination (infant or child) (in remission) F98.21
- sacrum, sacrococcygeal NEC M53.3
- schizoaffective F25.9
- schizoid of childhood F84.5
- schizophrenia spectrum and other psychotic disorder F29
- schizophreniform F20.81
- schizotypal (personality) F21
- secretion, thyrocalcitonin E07.0
- seizure G40.909
- semantic pragmatic F80.89
- sense of smell R43.1
- separation anxiety, of childhood F93.0
- shyness, of childhood and adolescence F40.10
- sibling rivalry F93.8
- sinus (nasal) J34.9
- skin L98.9
- SLC13A5 Citrate Transporter Disorder E74.820
- sleep G47.9
- sleep-wake pattern or schedule G47.9
- soft tissue M79.9
- somatic symptom F45.1
- somatization F45.0
- somatoform F45.9
- speech R47.9
- speech-sound F80.0
- spelling (specific) F81.81
- stereotyped, habit or movement F98.4
- stress F43.9
- sulfur-bearing amino-acid metabolism E72.10
- sweat gland (eccrine) L74.9
- synovium M67.90
- temperature regulation, newborn P81.9
- temporomandibular joint M26.60
- tendon M67.90
- thoracic root (nerve) NEC G54.3
- thyrocalcitonin hypersecretion E07.0
- thyroid (gland) E07.9
- tooth K08.9
- Tourette's F95.2
- trance and possession F44.89
- transvestic F65.1
- trauma and stressor-related NOS F43.9
- tryptophan metabolism E70.5
- tubular, phosphate-losing N25.0
- tubulo-renal function, impaired N25.9
- tympanic membrane H73.9
- unsocialized aggressive F91.1
- urea cycle metabolism E72.20
- ureter (in) N28.9
- urethra N36.9
- urinary system N39.9
- vestibular function H81.9
- vision, binocular H53.30
- vitreous body H43.9
- voice R49.9
- voyeuristic F65.3
- white blood cells D72.9
- withdrawing, child or adolescent F40.10
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions11never code together
- certain conditions originating in the perinatal period (P04-P96)P04-P96
- certain infectious and parasitic diseases (A00-B99)A00-B99
- complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
- endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
- lipomelanotic reticulosis (I89.8)I89.8
- neoplasms (C00-D49)C00-D49
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
- systemic connective tissue disorders (M30-M36)M30-M36
- viral warts (B07.-)B07.-
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes2
Official Guidelines11names this code
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
Codes in category L89, Pressure ulcer, identify the site and stage of the pressure ulcer. The ICD-10-CM classifies pressure ulcer stages based on severity, which is designated by stages 1-4, deep tissue pressure injury, unspecified stage, and unstageable. Assign as many codes from category L89 as needed to identify all the pressure ulcers the patient has, if applicable. See Section I.B.14. for pressure ulcer stage documentation by clinicians other than patient's provider.
Assignment of the code for unstageable pressure ulcer (L89.--0) should be based on the clinical documentation. These codes are used for pressure ulcers whose stage cannot be clinically determined (e.g., the ulcer is covered by eschar or has been treated with a skin or muscle graft). This code should not be confused with the codes for unspecified stage (L89.--9). When there is no documentation regarding the stage of the pressure ulcer, assign the appropriate code for unspecified stage (L89.-- 9). If during an encounter, the stage of an unstageable pressure ulcer is revealed after debridement, assign only the code for the stage revealed following debridement.
Assignment of the pressure ulcer stage code should be guided by clinical documentation of the stage or documentation of the terms found in the Alphabetic Index. For clinical terms describing the stage that are not found in the Alphabetic Index, and there is no documentation of the stage, the provider should be queried.
No code is assigned if the documentation states that the pressure ulcer is completely healed at the time of admission.
Pressure ulcers described as healing should be assigned the appropriate pressure ulcer stage code based on the documentation in the medical record. If the documentation does not provide information about the stage of the healing pressure ulcer, assign the appropriate code for unspecified stage. If the documentation is unclear as to whether the patient has a current (new) pressure ulcer or if the patient is being treated for a healing pressure ulcer, query the provider. For ulcers that were present on admission but healed at the time of discharge, assign the code for the site and stage of the pressure ulcer at the time of admission.
stage during the admission If a patient is admitted to an inpatient hospital with a pressure ulcer at one stage and it progresses to a higher stage, two separate codes should be assigned: one code for the site and stage of the ulcer on admission and a second code for the same ulcer site and the highest stage reported during the stay.
For pressure-induced deep tissue damage or deep tissue pressure injury, assign only the appropriate code for pressure-induced deep tissue damage (L89.--6).
healed No code is assigned if the documentation states that the non-pressure ulcer is completely healed at the time of admission.
Non-pressure ulcers described as healing should be assigned the appropriate non-pressure ulcer code based on the documentation in the medical record. If the documentation does not provide information about the severity of the healing non-pressure ulcer, assign the appropriate code for unspecified severity. If the documentation is unclear as to whether the patient has a current (new) non-pressure ulcer or if the patient is being treated for a healing non-pressure ulcer, query the provider. For ulcers that were present on admission but healed at the time of discharge, assign the code for the site and severity of the non-pressure ulcer at the time of admission.
If a patient is admitted to an inpatient hospital with a non-pressure ulcer at one severity level and it progresses to a higher severity level, two separate codes should be assigned: one code for the site and severity level of the ulcer on admission and a second code for the same ulcer site and the highest severity level reported during the stay. See Section I.B.14. for pressure ulcer stage documentation by clinicians other than patient's provider
Index entries leading here1
- Disorder (of) — see also Disease
- nail, in diseases classified elsewhere L62
Medications1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.